RadNet, Inc. Common Stock (RDNT) is a publicly traded Healthcare sector company. As of October 26, 2026, RDNT trades at $67.85 with a market cap of $5.54B and a P/E ratio of -262.35. RDNT moved -0.40% today. Year to date, RDNT is -1.27%; over the trailing twelve months it is -16.02%. Its 52-week range spans $45.00 to $85.84. Analyst consensus is strong buy with an average price target of $91.00. Rallies surfaces RDNT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for RDNT combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $67.85 |
| Market Cap | $5.54B |
| P/E Ratio | -262.35 |
| EPS | $-0.27 |
| Dividend Yield | 0.00% |
| 52-Week High | $85.84 |
| 52-Week Low | $45.00 |
| Volume | 201.40K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.27B |
| Net Income | $19.27M |
| Gross Margin | 0.00% |
4 analysts cover RDNT: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $91.00.